# Effectiveness and Safety of Autologous Adipose-Derived Regenerative Cells for the Treatment of Urethral Strictures

> **NCT01889888** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Burnasyan Federal Medical Biophysical Center** · enrollment: 12 (estimated)

## Conditions studied

- Urethral Strictures in Males

## Interventions

- **OTHER:** Submucosal injection of ADRC

## Key facts

- **NCT ID:** NCT01889888
- **Lead sponsor:** Burnasyan Federal Medical Biophysical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-06
- **Primary completion:** 2014-10
- **Final completion:** 2015-05
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2013-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01889888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01889888, "Effectiveness and Safety of Autologous Adipose-Derived Regenerative Cells for the Treatment of Urethral Strictures". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01889888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*